This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ayumi Pharmaceutical Corporation. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Iwao Seki: Innovator in Medicinal Chemistry
Introduction
Iwao Seki is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on BRD4 inhibitors. His research has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Iwao Seki holds a patent for a compound titled "6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative." This invention demonstrates BRD4 inhibitory activity, making it useful as a medicament, especially for the prophylaxis and therapeutic treatment of diseases associated with BRD4. He has 1 patent to his name.
Career Highlights
Seki is currently associated with Ayumi Pharmaceutical Corporation, where he continues to advance his research in medicinal chemistry. His work is characterized by a commitment to developing innovative solutions for complex health issues.
Collaborations
Some of his notable coworkers include Hiroyuki Aono and Miwa Imamura, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Iwao Seki's contributions to medicinal chemistry, particularly through his patent on BRD4 inhibitors, highlight his role as an innovator in the field. His work at Ayumi Pharmaceutical Corporation continues to pave the way for advancements in therapeutic agents.